Upgrade to SI Premium - Free Trial

Brainstorm Cell Therapeutics (BCLI)

0.33 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/28/24)

Latest Headlines

Form 4 BRAINSTORM CELL THERAPEU For: Mar 11 Filed by: Lindborg Stacy March 13, 2024 8:58 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Mar 11 Filed by: Yablonka Uri March 13, 2024 8:57 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Mar 11 Filed by: Patlis Alla March 13, 2024 8:56 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Mar 11 Filed by: Lebovits Chaim March 13, 2024 8:55 PM - SEC Filing Brainstorm Cell Therapeutics (BCLI) to Unveil Phase 3b NurOwn Trial Design at MDA Clinical and Scientific Conference February 27, 2024 6:32 AM - StreetInsider BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific Conference February 27, 2024 6:30 AM - PR NewsWire Brainstorm Cell Therapeutics (BCLI) Submits SPA Request to FDA for US Phase 3b Trial of NurOwn February 23, 2024 6:00 AM - StreetInsider BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS February 23, 2024 6:00 AM - PR NewsWire BrainStorm Cell Therapeutics to Present at European Life Sciences CEO Forum February 13, 2024 6:30 AM - PR NewsWire Form SC 13G/A BRAINSTORM CELL THERAPEU Filed by: Ness Kevin Dean February 12, 2024 10:06 AM - SEC Filing BCLI FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline January 1, 2024 1:55 PM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Brainstorm Cell, SolarEdge, and Barclays and Encourages Investors to Contact the Firm December 28, 2023 9:00 PM - StreetInsider BCLI DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action Commenced December 28, 2023 5:03 PM - StreetInsider BRAINSTORM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Brainstorm To Contact Him Directly To Dis December 27, 2023 9:30 AM - StreetInsider Brainstorm Cell Therapeutics (BCLI) Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments December 26, 2023 7:30 AM - StreetInsider BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments December 26, 2023 7:30 AM - PR NewsWire BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm December 24, 2023 9:00 PM - StreetInsider BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm December 20, 2023 9:00 PM - StreetInsider Form 8-K BRAINSTORM CELL THERAPEU For: Dec 18 December 20, 2023 5:05 PM - SEC Filing Brainstorm Cell Therapeutics (BCLI) Issues 2023 Letter to Shareholders December 20, 2023 9:01 AM - StreetInsider BrainStorm Issues 2023 Letter to Shareholders December 20, 2023 9:00 AM - PR NewsWire Full Article List